Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-04-17
1997-05-13
Sayala, Chhaya D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530380, 530382, 530385, A61K 3816
Patent
active
056292872
ABSTRACT:
A depot formulation comprising fibronectin or a fragment thereof, a growth factor binding agent linked thereto and growth factor bound to the binding agent is used to promote wound healing in combination with macroscopically oriented cell adhesion proteins, the depot formulations allow the healing process to be directed to afford stronger or more cosmetically acceptable results.
REFERENCES:
patent: 4885295 (1989-12-01), Bell
patent: 4955892 (1990-09-01), Daniloff
patent: 4973466 (1990-11-01), Reich
patent: 4981841 (1991-01-01), Gibson
patent: 4983580 (1991-01-01), Gibson
patent: 5013732 (1991-05-01), Bell
patent: 5036056 (1991-07-01), Kludas
patent: 5043288 (1991-08-01), Motsenbocker
patent: 5043429 (1991-08-01), Zimmerman
patent: 5053388 (1991-10-01), Gibson et al.
patent: 5104856 (1992-04-01), Esko et al.
patent: 5120828 (1992-06-01), Charonis
patent: 5266328 (1993-11-01), Skubitz et al.
patent: 5270300 (1993-12-01), Hunziker
Dijke, Peter et al., "Growth Factors for Wound Healing", Biotechnology, vol. 7, pp. 793-798, Aug. 1989.
Baxter, Robert et al., "Glycosaminoglycans inhibit formation . . . ", Biochem. J., vol. 271, pp. 773-777, 1990.
Sommer, A et al., "Modern Concepts of Insulin-Like Growth Factors", Ed. Martin Spencer, Elsevier Publishers, pp. 715-728, Jan. 1991.
Mueller, Reid et al., "Modern Concepts of Insulin-Like Growth Factors", Ed. Martin Spencer, Elsevier, pp. 185-192, Jan. 1991.
Simmons, "Evaluation of collagen cross-linking techniques for the stabilization of tissue matrices", Biotechnol-Appl-Biochem., 1993 Feb; 17 (Pt 1):23-9.
Freed, "Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease", N. Engl. J. Med., 1992 Nov. 26; 327(22):1549-55.
Gershon, "Compliance and ultimate strength of composite arterial prostheses", Biomaterials, 1992; 13(1):38-43.
Ricci, "In-vitro tendon cell growth on synthetic fiber implant materials:biological implications", Bull. Hosp. Jt. Dis. Orthop. Inst., 1990 Fall; 50(2):126-38.
Matsuda, "Development of a novel artificial matrix with cell adhesion peptides for cell culture and artificial and hybrid organs", ASAIO. Trans. 1989 Jul.-Sep.; 35(3):677-9.
Jakobson, "A simple method for shell-less cultivation of chick embryos", Pharmacol-Toxicol, 1989 Feb.; 64(2):193-5.
Brown, "Therapeutic Uses of Cell-Matrix Adhesive Protein", Current Opinion in Therapeutic Patents, Aug. 1993, pp. 1117-1140.
Blun Gordon
Brown Robert
Sayala Chhaya D.
University College London
LandOfFree
Depot formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Depot formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depot formulations will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1385410